id | C00023663 |
---|---|
Name | Alternariol / 3,4',5-Trihydroxy-6'-methyl-dibenzo[a]pyrone |
CAS RN | 641-38-3 |
Standard InChI | InChI=1S/C14H10O5/c1-6-2-7(15)5-11-12(6)9-3-8(16)4-10(17)13(9)14(18)19-11/h2-5,15-17H,1H3 |
Standard InChI (Main Layer) | InChI=1S/C14H10O5/c1-6-2-7(15)5-11-12(6)9-3-8(16)4-10(17)13(9)14(18)19-11/h2-5,15-17H,1H3 |
Phytochemical cluster | No. 17 |
---|---|
KCF-S cluster | No. 54 |
By standard InChI | CHEMBL519982 |
---|---|
By standard InChI Main Layer | CHEMBL519982 |
By LinkDB | C16838 |
---|
By CAS RN | C005197 |
---|
class name | count |
---|
family name | count |
---|---|
Pleosporaceae | 3 |
KNApSAcK organism | *ID | *family | *plant class | *kingdom |
---|---|---|---|---|
Alternaria dauci | 48095 | Pleosporaceae | Fungi | |
Alternaria sp. | 5598 | Pleosporaceae | Fungi | |
Alternaria tenuis NRRL 5255,5872,5873 | 5598 | Pleosporaceae | Fungi |
accession | description | class description | compound | assay ID (# of activities) |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|---|
P08069 | Insulin-like growth factor 1 receptor | TK tyrosine-protein kinase INSR subfamily | CHEMBL519982 |
CHEMBL962870
(1)
CHEMBL965368
(1)
|
1 / 3 |
O14965 | Aurora kinase A | Aur | CHEMBL519982 |
CHEMBL966176
(1)
|
0 / 0 |
P68400 | Casein kinase II subunit alpha | Ck2 | CHEMBL519982 |
CHEMBL962879
(1)
|
0 / 0 |
P24941 | Cyclin-dependent kinase 2 | Cdc2 | CHEMBL519982 |
CHEMBL966179
(1)
|
0 / 0 |
O00444 | Serine/threonine-protein kinase PLK4 | PLK serine/threonine protein kinase subfamily | CHEMBL519982 |
CHEMBL966209
(1)
|
0 / 0 |
P00533 | Epidermal growth factor receptor | TK tyrosine-protein kinase EGFR subfamily | CHEMBL519982 |
CHEMBL962866
(1)
|
1 / 11 |
P36888 | Receptor-type tyrosine-protein kinase FLT3 | Pdgfr | CHEMBL519982 |
CHEMBL962874
(1)
CHEMBL965370
(1)
|
1 / 1 |
P54760 | Ephrin type-B receptor 4 | Eph | CHEMBL519982 |
CHEMBL962867
(1)
|
0 / 0 |
Q05397 | Focal adhesion kinase 1 | Fak | CHEMBL519982 |
CHEMBL962869
(1)
|
0 / 0 |
Q02763 | Angiopoietin-1 receptor | Tie | CHEMBL519982 |
CHEMBL965366
(1)
|
1 / 1 |
O60285 | NUAK family SNF1-like kinase 1 | CAMK serine/threonine protein kinase NUAK subfamily | CHEMBL519982 |
CHEMBL966175
(1)
|
0 / 0 |
P06213 | Insulin receptor | TK tyrosine-protein kinase INSR subfamily | CHEMBL519982 |
CHEMBL962875
(1)
|
5 / 4 |
P04626 | Receptor tyrosine-protein kinase erbB-2 | TK tyrosine-protein kinase EGFR subfamily | CHEMBL519982 |
CHEMBL962868
(1)
|
5 / 10 |
P09619 | Platelet-derived growth factor receptor beta | Pdgfr | CHEMBL519982 |
CHEMBL962877
(1)
|
5 / 1 |
P12931 | Proto-oncogene tyrosine-protein kinase Src | Src | CHEMBL519982 |
CHEMBL962871
(1)
|
0 / 0 |
Q96GD4 | Aurora kinase B | Aur | CHEMBL519982 |
CHEMBL966177
(1)
CHEMBL965367
(1)
|
0 / 0 |
P35968 | Vascular endothelial growth factor receptor 2 | Vegfr | CHEMBL519982 |
CHEMBL962872
(1)
CHEMBL965369
(1)
|
1 / 0 |
P08581 | Hepatocyte growth factor receptor | TK tyrosine-protein kinase MET subfamily | CHEMBL519982 |
CHEMBL962876
(1)
|
2 / 3 |
P35916 | Vascular endothelial growth factor receptor 3 | Vegfr | CHEMBL519982 |
CHEMBL962873
(1)
|
2 / 1 |
P41279 | Mitogen-activated protein kinase kinase kinase 8 | Ste11 | CHEMBL519982 |
CHEMBL966181
(1)
|
0 / 0 |
P53350 | Serine/threonine-protein kinase PLK1 | PLK serine/threonine protein kinase subfamily | CHEMBL519982 |
CHEMBL962878
(1)
|
0 / 0 |
P31749 | RAC-alpha serine/threonine-protein kinase | Akt | CHEMBL519982 |
CHEMBL966174
(1)
|
4 / 1 |
P11802 | Cyclin-dependent kinase 4 | CMGC serine/threonine protein kinase family | CHEMBL519982 |
CHEMBL966180
(1)
|
1 / 3 |
compound | gene | gene name | gene description | interaction | interaction type | form |
reference
pmid |
---|---|---|---|---|---|---|---|
C005197 | 836 |
CASP3
CPP32 CPP32B SCA-1 |
caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) | alternariol results in increased activity of CASP3 protein |
increases activity
|
protein |
22542754
|
C005197 | 842 |
CASP9
APAF-3 APAF3 ICE-LAP6 MCH6 PPP1R56 |
caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) | alternariol results in increased activity of CASP9 protein |
increases activity
|
protein |
22542754
|
C005197 | 2938 |
GSTA1
GST2 GSTA1-1 GTH1 |
glutathione S-transferase alpha 1 (EC:2.5.1.18) | alternariol affects the localization of GSTA1 mRNA |
affects localization
|
mRNA |
23154127
|
C005197 | 2939 |
GSTA2
GST2 GSTA2-2 GTA2 GTH2 |
glutathione S-transferase alpha 2 (EC:2.5.1.18) | alternariol affects the localization of GSTA2 mRNA |
affects localization
|
mRNA |
23154127
|
C005197 | 4780 |
NFE2L2
NRF2 |
nuclear factor, erythroid 2-like 2 | alternariol affects the localization of NFE2L2 protein |
affects localization
|
protein |
23154127
|
C005197 | 7157 |
TP53
BCC7 LFS1 P53 TRP53 |
tumor protein p53 | alternariol results in increased expression of TP53 protein |
increases expression
|
protein |
22542754
|
OMIM | preferred title | UniProt |
---|---|---|
#615007 | Basal ganglia calcification, idiopathic, 4; ibgc4 |
P09619
|
#114480 | Breast cancer |
P31749
|
#114500 | Colorectal cancer; crc |
P31749
|
#615109 | Cowden syndrome 6; cws6 |
P31749
|
#610549 | Diabetes mellitus, insulin-resistant, with acanthosis nigricans |
P06213
|
#125853 | Diabetes mellitus, noninsulin-dependent; niddm |
P06213
|
#246200 | Donohue syndrome |
P06213
|
#613659 | Gastric cancer |
P04626
|
#137215 | Gastric cancer, hereditary diffuse; hdgc |
P04626
|
#137800 | Glioma susceptibility 1; glm1 |
P04626
|
#602089 | Hemangioma, capillary infantile |
P35916
P35968 |
#114550 | Hepatocellular carcinoma |
P08581
|
#609968 | Hyperinsulinemic hypoglycemia, familial, 5; hhf5 |
P06213
|
#270450 | Insulin-like growth factor i, resistance to |
P08069
|
#607785 | Juvenile myelomonocytic leukemia; jmml |
P09619
|
#601626 | Leukemia, acute myeloid; aml |
P09619
P36888 |
#211980 | Lung cancer |
P00533
P04626 |
#153100 | Lymphedema, hereditary, ia |
P35916
|
#609048 | Melanoma, cutaneous malignant, susceptibility to, 3; cmm3 |
P11802
|
#131440 | Myeloproliferative disorder, chronic, with eosinophilia |
P09619
|
#228550 | Myofibromatosis, infantile, 1; imf1 |
P09619
|
#167000 | Ovarian cancer |
P04626
|
#262190 | Pineal hyperplasia, insulin-resistant diabetes mellitus, and somatic abnormalities |
P06213
|
#176920 | Proteus syndrome |
P31749
|
#605074 | Renal cell carcinoma, papillary, 1; rccp1 |
P08581
|
#600195 | Venous malformations, multiple cutaneous and mucosal; vmcm |
Q02763
|
KEGG | disease name | UniProt |
---|---|---|
H00016 | Oral cancer |
P00533
(related)
P00533 (marker) |
H00017 | Esophageal cancer |
P00533
(related)
|
H00018 | Gastric cancer |
P00533
(related)
P04626 (related) P08581 (related) |
H00022 | Bladder cancer |
P00533
(related)
P04626 (related) |
H00028 | Choriocarcinoma |
P00533
(related)
P04626 (related) |
H00030 | Cervical cancer |
P00533
(related)
P04626 (related) P11802 (related) |
H00042 | Glioma |
P00533
(related)
P00533 (marker) P09619 (related) P11802 (related) |
H00055 | Laryngeal cancer |
P00533
(related)
P00533 (marker) |
H00019 | Pancreatic cancer |
P04626
(related)
|
H00026 | Endometrial Cancer |
P04626
(related)
|
H00027 | Ovarian cancer |
P04626
(related)
|
H00031 | Breast cancer |
P04626
(related)
P04626 (marker) |
H00046 | Cholangiocarcinoma |
P04626
(related)
P08581 (related) |
H00719 | Leprechaunism |
P06213
(related)
|
H00942 | Rabson-Mendenhall syndrome |
P06213
(related)
|
H01228 | Insulin-resistant diabetes mellitus with acanthosis nigricans (IRAN) |
P06213
(related)
|
H01267 | Familial hyperinsulinemic hypoglycemia (HHF) |
P06213
(related)
|
H00015 | Malignant pleural mesothelioma |
P08069
(related)
|
H00050 | Synovial sarcoma |
P08069
(related)
|
H01274 | Growth delay due to insulin-like growth factor I resistance |
P08069
(related)
|
H00021 | Renal cell carcinoma |
P08581
(related)
|
H00038 | Malignant melanoma |
P11802
(related)
|
H00539 | PTEN hamartoma tumor syndrome (PHTS) |
P31749
(related)
|
H00535 | Lymphedemas |
P35916
(related)
|
H00003 | Acute myeloid leukemia (AML) |
P36888
(related)
|
H00531 | Venous malformations |
Q02763
(related)
|